Everyone with these 27 NHS health conditions can still get £812 DWP PIP benefits
The DWP's PIP benefits are still available despite potential changes and could get you £812 a month if you have one of these ...
University of California, San Francisco9d
UCSF Among First in U.S. to Receive New Pulmonary Care Designation
The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...
Healio10d
25.4% of patients with bronchiectasis had symptoms for more than 10 years before diagnosis
Prior to being diagnosed with bronchiectasis, many patients reported living with symptoms for multiple years, according to ...
Medical Dialogues10d
Colistimethate sodium effective against bronchiectasis and P. aeruginosa infection: Study
According to PROMIS-I data published in the journal of The Lancet Respiratory Medicine showed that individuals with ...
Frontiers24d
Impact of physical activity on all-cause mortality in individuals with non-cystic fibrosis bronchiectasis
Background: Little information is available regarding whether active physical activity lowers mortality risk in individuals with bronchiectasis. Methods: We used the Korean National Health Insurance ...
Investing25d
FDA sets PDUFA date for Insmed's bronchiectasis drug
This Phase 3 study is the largest ever conducted for bronchiectasis, a chronic lung condition characterized by the widening of the airways, leading to recurrent infections, inflammation ...
Business Insider25d
Insmed: FDA won’t hold advisory meeting to discuss NDA for brensocatib
“We are committed to working closely with the agency to successfully complete the review and potentially bring forward this much-needed treatment for patients with bronchiectasis.” See what ...
Business Wire25d
AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease
today announced its submission of an amended statistical analysis plan to the FDA selecting the Quality of Life – Bronchiectasis (QOL-B) respiratory domain patient reported outcome (PRO ...